{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:56:52Z","timestamp":1790301412381,"version":"4.1.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001555","name":"Leukaemia & Blood Cancer New Zealand","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001555","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Marijanna Kumerich"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cancergen.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T04:32:49Z","timestamp":1414384369000},"page":"192-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases"],"prefix":"10.1016","volume":"208","author":[{"given":"Martin","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Bohlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2014.10.005_bib1","doi-asserted-by":"crossref","first-page":"f1660","DOI":"10.1136\/bmj.f1660","article-title":"Leukaemia update. Part 1: diagnosis and management","volume":"346","author":"Grigoropoulos","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.cancergen.2014.10.005_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib3","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2014.10.005_bib4","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","article-title":"The polycomb-group gene Ezh2 is required for early mouse development","volume":"21","author":"O'Carroll","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2014.10.005_bib7","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.1093\/nar\/gkr613","article-title":"Handpicking epigenetic marks with PHD fingers","volume":"39","author":"Musselman","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.sbi.2010.09.012","article-title":"Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies","volume":"20","author":"Justin","year":"2010","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nsmb1338","article-title":"How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers","volume":"14","author":"Taverna","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cancergen.2014.10.005_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0955-0674(93)90080-A","article-title":"Protein methylation","volume":"5","author":"Clarke","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/bi00889a003","article-title":"The occurrence of epsilon-N-methyl lysine in histones","volume":"3","author":"Murray","year":"1964","journal-title":"Biochemistry"},{"key":"10.1016\/j.cancergen.2014.10.005_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1747-0285.2011.01135.x","article-title":"Chemogenetic analysis of human protein methyltransferases","volume":"78","author":"Richon","year":"2011","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.cancergen.2014.10.005_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nrm1761","article-title":"The diverse functions of histone lysine methylation","volume":"6","author":"Martin","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2164-15-331","article-title":"Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells","volume":"15","author":"Rhie","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cancergen.2014.10.005_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1232542","article-title":"Genome-wide quantitative enhancer activity maps identified by STARR-seq","volume":"339","author":"Arnold","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2014.10.005_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/dvg.20534","article-title":"Analysis of epigenetic alterations to chromatin during development","volume":"47","author":"Minard","year":"2009","journal-title":"Genesis"},{"key":"10.1016\/j.cancergen.2014.10.005_bib20","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1242\/dev.02402","article-title":"Chromatin and epigenetics in development: blending cellular memory with cell fate plasticity","volume":"133","author":"Cavalli","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.cancergen.2014.10.005_bib21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1742-4658.2010.07609.x","article-title":"Mixed lineage leukemia: a structure-function perspective of the MLL1 protein","volume":"277","author":"Cosgrove","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng1092-113","article-title":"A\u00a0trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias","volume":"2","author":"Djabali","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib23","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1038\/sj.onc.1210760","article-title":"Hox genes in hematopoiesis and leukemogenesis","volume":"26","author":"Argiropoulos","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2014.10.005_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.genet.38.072902.091907","article-title":"Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins","volume":"38","author":"Ringrose","year":"2004","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrg1726","article-title":"Modulating Hox gene functions during animal body patterning","volume":"6","author":"Pearson","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/leu.2012.356","article-title":"The role of HOX genes in normal hematopoiesis and acute leukemia","volume":"27","author":"Alharbi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V92.1.108.413k11_108_117","article-title":"Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice","volume":"92","author":"Yagi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib28","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood.V90.5.1799","article-title":"Defects in yolk sac hematopoiesis in Mll-null embryos","volume":"90","author":"Hess","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2011-03-341081","article-title":"Identification and characterization of Hoxa9 binding sites in hematopoietic cells","volume":"119","author":"Huang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib30","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib31","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1128\/MCB.00924-09","article-title":"Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II","volume":"29","author":"Wang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.cell.2013.01.052","article-title":"H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation","volume":"152","author":"Lauberth","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jmb.2010.05.005","article-title":"Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription","volume":"400","author":"Chang","year":"2010","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib35","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.1073\/pnas.0503072102","article-title":"Global and Hox-specific roles for the MLL1 methyltransferase","volume":"102","author":"Guenther","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib36","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/sj.emboj.7601340","article-title":"Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase","volume":"25","author":"Allen","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/nar\/30.4.958","article-title":"The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation","volume":"30","author":"Birke","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib38","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.91.22.10610","article-title":"11q23 translocations split the \u201cAT-hook\u201d cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene","volume":"91","author":"Zeleznik-Le","year":"1994","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nsmb1128","article-title":"Regulation of MLL1 H3K4 methyltransferase activity by its core components","volume":"13","author":"Dou","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib42","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Yokoyama","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib43","first-page":"1931","article-title":"The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia","volume":"25","author":"De Braekeleer","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","article-title":"Secondary leukemias induced by topoisomerase-targeted drugs","volume":"1400","author":"Felix","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergen.2014.10.005_bib45","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1073\/pnas.92.11.4922","article-title":"Involvement of the ALL-1 gene in a solid tumor","volume":"92","author":"Baffa","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib46","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib48","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL\u00a0recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molmed.2004.08.005","article-title":"MLL: a histone methyltransferase disrupted in leukemia","volume":"10","author":"Hess","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cancergen.2014.10.005_bib50","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1182\/blood-2008-01-134056","article-title":"The PHD fingers of MLL block MLL fusion protein-mediated transformation","volume":"112","author":"Muntean","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib52","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2014.04.015","article-title":"The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis","volume":"7","author":"Mishra","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.cancergen.2014.10.005_bib53","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2009-06-229542","article-title":"The AF4. MLL fusion protein is capable of inducing ALL in mice without requirement of MLL. AF4","volume":"115","author":"Bursen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.leu.2403746","article-title":"New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes","volume":"19","author":"Kohlmann","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","article-title":"Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation","volume":"102","author":"Ferrando","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/sj.onc.1204174","article-title":"Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t (4 : 11) abnormality","volume":"20","author":"Rozovskaia","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2014.10.005_bib57","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1101\/gad.1602107","article-title":"Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential","volume":"21","author":"Wong","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2014.10.005_bib58","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.1111603","article-title":"Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9","volume":"17","author":"Ayton","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2014.10.005_bib59","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood-2003-10-3722","article-title":"Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9","volume":"103","author":"So","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib60","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","article-title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization","volume":"24","author":"Zeisig","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10930-010-9242-8","article-title":"Characterization of the DOT1L network: implications of diverse roles for DOT1L","volume":"29","author":"Park","year":"2010","journal-title":"Protein J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib62","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1038\/sj.onc.1208699","article-title":"The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin","volume":"24","author":"Zeisig","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2014.10.005_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exphem.2010.09.003","article-title":"MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with\u00a0genes critical for leukemia","volume":"39","author":"Monroe","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A\u00a0higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib66","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A\u00a0role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-genet-110711-155440","article-title":"Control of transcriptional elongation","volume":"47","author":"Kwak","year":"2013","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib69","doi-asserted-by":"crossref","first-page":"e1000249","DOI":"10.1371\/journal.pbio.1000249","article-title":"Misguided transcriptional elongation causes mixed lineage leukemia","volume":"7","author":"Mueller","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib71","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","article-title":"Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation","volume":"117","author":"Jo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib72","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1158\/0008-5472.CAN-10-3294","article-title":"Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes","volume":"70","author":"Chang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib73","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2012-11-465120","article-title":"Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l","volume":"121","author":"Deshpande","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib75","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1093\/emboj\/19.17.4655","article-title":"Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia","volume":"19","author":"Lavau","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib76","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1073\/pnas.94.16.8732","article-title":"MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)","volume":"94","author":"Sobulo","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib77","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/MCB.21.7.2249-2258.2001","article-title":"MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein","volume":"21","author":"Ernst","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib78","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ncb1642","article-title":"Protein arginine-methyltransferase-dependent oncogenesis","volume":"9","author":"Cheung","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib79","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood-2003-11-3817","article-title":"The small oligomerization domain of gephyrin converts MLL to an oncogene","volume":"103","author":"Eguchi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1535-6108(03)00188-0","article-title":"Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias","volume":"4","author":"So","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib81","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1535-6108(03)00214-9","article-title":"Dimerization of MLL fusion proteins immortalizes hematopoietic cells","volume":"4","author":"Martin","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib82","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/emboj\/19.5.843","article-title":"Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene","volume":"19","author":"Dobson","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2003-06-2163","article-title":"Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies","volume":"103","author":"Poppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib84","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1098-2264(199910)26:2<166::AID-GCC9>3.0.CO;2-P","article-title":"Amplification of the 11q23 region in acute myeloid leukemia","volume":"26","author":"Avet-Loiseau","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2014.10.005_bib85","first-page":"774","article-title":"MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype","volume":"10","author":"Yu","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib86","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1073\/pnas.91.13.6236","article-title":"ALL-1 partial duplication in acute leukemia","volume":"91","author":"Schichman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib87","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood-2005-01-0204","article-title":"The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy","volume":"106","author":"Whitman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib88","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1172\/JCI25546","article-title":"Mll partial tandem duplication induces aberrant Hox expression in\u00a0vivo via specific epigenetic alterations","volume":"116","author":"Dorrance","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cancergen.2014.10.005_bib89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajhg.2012.06.008","article-title":"De novo mutations in MLL cause Wiedemann-Steiner syndrome","volume":"91","author":"Jones","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0092-8674(03)00114-4","article-title":"Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase","volume":"112","author":"Min","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib91","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0960-9822(02)00901-6","article-title":"Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain","volume":"12","author":"Feng","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib92","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.154","article-title":"Combinatorial patterns of histone acetylations and methylations in the human genome","volume":"40","author":"Wang","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib93","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/MCB.02076-07","article-title":"DOT1L\/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells","volume":"28","author":"Steger","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib94","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1128\/MCB.01529-06","article-title":"Profile of histone lysine methylation across transcribed mammalian chromatin","volume":"26","author":"Vakoc","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib95","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(03)00091-1","article-title":"The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation","volume":"11","author":"Krogan","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib96","doi-asserted-by":"crossref","first-page":"e1000190","DOI":"10.1371\/journal.pgen.1000190","article-title":"The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure","volume":"4","author":"Jones","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib97","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/stem.86","article-title":"ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L","volume":"27","author":"Barry","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.cancergen.2014.10.005_bib98","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1128\/MCB.25.19.8430-8443.2005","article-title":"Role of Dot1-dependent histone H3 methylation in G1 and S phase DNA damage checkpoint functions of Rad9","volume":"25","author":"Wysocki","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib99","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1074\/jbc.M414453200","article-title":"The DNA damage checkpoint response requires histone H2B ubiquitination by Rad6-Bre1 and H3 methylation by Dot1","volume":"280","author":"Giannattasio","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib101","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.93.10.4804","article-title":"The t (10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family","volume":"93","author":"Dreyling","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib102","first-page":"4662","article-title":"MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis","volume":"91","author":"Dreyling","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib103","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-06-3749","article-title":"Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice","volume":"67","author":"Caudell","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib104","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ncb1464","article-title":"Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L","volume":"8","author":"Okada","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2009-03-209395","article-title":"Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias","volume":"114","author":"Lin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib106","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Van Vlierberghe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib107","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/emboj\/16.11.3219","article-title":"Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres","volume":"16","author":"Laible","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib108","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vir\u00e9","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib109","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2014.10.005_bib110","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2008.12.043","article-title":"Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells","volume":"136","author":"Ezhkova","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib111","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","article-title":"The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion","volume":"107","author":"Kamminga","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib112","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3324\/haematol.2012.074195","article-title":"The trithorax protein partner menin acts in tandem with EZH2 to suppress C\/EBP\u03b1 and differentiation in MLL-AF9 leukemia","volume":"98","author":"Thiel","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2014.10.005_bib113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5966\/sctm.2012-0036","article-title":"EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter","volume":"2","author":"van Vlerken","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.cancergen.2014.10.005_bib114","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.2010.028605","article-title":"Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia\/lymphoma as a target for epigenetic therapy","volume":"96","author":"Sasaki","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2014.10.005_bib115","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ijc.23683","article-title":"The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells","volume":"123","author":"Wagener","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2014.10.005_bib116","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","article-title":"EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast","volume":"24","author":"Bachmann","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib117","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib118","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib120","article-title":"Oncogenic Y641 mutations in EZH2 prevent Jak2\/\u03b2-TrCP-mediated degradation","author":"Sahasrabuddhe","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2014.10.005_bib121","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib122","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib123","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-13-1597","article-title":"EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations","volume":"20","author":"Guo","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib124","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib125","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","article-title":"EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis","volume":"116","author":"Velichutina","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib126","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00277-010-1128-5","article-title":"Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring","volume":"90","author":"Xu","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib127","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0609.2008.01083.x","article-title":"Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia","volume":"81","author":"Grubach","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncomms1623","article-title":"Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease","volume":"3","author":"Herrera-Merchan","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.cancergen.2014.10.005_bib129","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","article-title":"Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia","volume":"120","author":"Tanaka","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2013.80","article-title":"Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies","volume":"27","author":"Khan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib132","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/leu.2010.167","article-title":"Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies","volume":"24","author":"Makishima","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib133","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib134","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergen.2014.10.005_bib135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2011.10","article-title":"Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib136","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1182\/blood-2011-06-363424","article-title":"EZH2 mutational status predicts poor survival in myelofibrosis","volume":"118","author":"Guglielmelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib137","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib138","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2407-10-401","article-title":"Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias","volume":"10","author":"Rocquain","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2014.10.005_bib139","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib140","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/leu.2012.146","article-title":"EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms","volume":"26","author":"Ueda","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib141","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2011-07-367243","article-title":"Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms","volume":"119","author":"Score","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib142","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1172\/JCI70739","article-title":"Myelodysplastic syndromes are induced by histone methylation\u2013altering ASXL1 mutations","volume":"123","author":"Inoue","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cancergen.2014.10.005_bib143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib144","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib145","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1200\/JCO.2010.33.4938","article-title":"Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes","volume":"29","author":"Thol","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib146","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib147","doi-asserted-by":"crossref","first-page":"35261","DOI":"10.1074\/jbc.M504012200","article-title":"Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase","volume":"280","author":"Sun","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib148","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.emboj.7601967","article-title":"Dynamic histone H3 methylation during gene induction: HYPB\/Setd2 mediates all H3K36 trimethylation","volume":"27","author":"Edmunds","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib149","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ng.2894","article-title":"Identification of functional cooperative mutations of SETD2 in human acute leukemia","volume":"46","author":"Zhu","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib150","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1038\/ncomms4469","article-title":"Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia","volume":"5","author":"Mar","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.cancergen.2014.10.005_bib151","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature08086","article-title":"A\u00a0histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome","volume":"460","author":"Nimura","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib152","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1074\/jbc.M110.204115","article-title":"The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation","volume":"286","author":"Qiao","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib153","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/gcc.22064","article-title":"NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia","volume":"52","author":"Shiba","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2014.10.005_bib154","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib155","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V98.4.1264","article-title":"A\u00a0novel gene, NSD1, is fused to NUP98 in the t (5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia","volume":"98","author":"Jaju","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib156","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ncb1608","article-title":"NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis","volume":"9","author":"Wang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib157","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V99.10.3857","article-title":"NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)","volume":"99","author":"Rosati","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib158","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature04433","article-title":"Histone demethylation by a family of JmjC domain-containing proteins","volume":"439","author":"Tsukada","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib159","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib160","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1074\/jbc.M109.003087","article-title":"A\u00a0novel mammalian flavin-dependent histone demethylase","volume":"284","author":"Karytinos","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2014.05.009","article-title":"Targeting histone lysine demethylases - Progress, challenges, and the future","author":"Thinnes","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergen.2014.10.005_bib162","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd4154","article-title":"Histone lysine demethylases as targets for anticancer therapy","volume":"12","author":"H\u00f8jfeldt","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cancergen.2014.10.005_bib163","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/mc.20878","article-title":"JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia","volume":"52","author":"Nakamura","year":"2013","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.cancergen.2014.10.005_bib164","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1128\/MCB.00133-12","article-title":"KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia","volume":"32","author":"Kim","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib165","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood-2010-10-312736","article-title":"KDM2b\/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia","volume":"117","author":"He","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib166","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2013-08-522094","article-title":"shRNA screening identifies JMJD1C as being required for leukemia maintenance","volume":"123","author":"Sroczynska","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib167","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","article-title":"The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells","volume":"21","author":"Harris","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib168","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/leu.2012.56","article-title":"Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia","volume":"26","author":"Mar","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib169","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2010-10-311019","article-title":"Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A","volume":"118","author":"Jankowska","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications\u2013miswritten, misinterpreted and mis-erased in human cancers","volume":"10","author":"Chi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2014.10.005_bib171","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cancergen.2014.10.005_bib172","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"Cao","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.cancergen.2014.10.005_bib173","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/onc.2012.552","article-title":"Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics","volume":"32","author":"Copeland","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2014.10.005_bib174","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0163-7258(97)00089-2","article-title":"Biological effects of inhibitors of S-adenosylhomocysteine hydrolase","volume":"77","author":"Chiang","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cancergen.2014.10.005_bib175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molcel.2013.12.001","article-title":"Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia","volume":"53","author":"Cao","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib176","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/jm100139b","article-title":"Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction","volume":"53","author":"Karatas","year":"2010","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib177","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/ja306028q","article-title":"High-affinity, small-molecule peptidomimetic inhibitors of MLL1\/WDR5 protein-protein interaction","volume":"135","author":"Karatas","year":"2013","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.cancergen.2014.10.005_bib178","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20121280","article-title":"Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5","volume":"449","author":"Senisterra","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib179","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1096\/fj.10-171959","article-title":"Fine-tuning the stimulation of MLL1 methyltransferase activity by a histone H3-based peptide mimetic","volume":"25","author":"Avdic","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.cancergen.2014.10.005_bib180","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/jm401868d","article-title":"High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction","volume":"57","author":"He","year":"2014","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib181","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","article-title":"Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib182","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nchembio.773","article-title":"Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia","volume":"8","author":"Grembecka","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib183","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1158\/0008-5472.CAN-06-2369","article-title":"Interaction of MLL amino terminal sequences with menin is required for transformation","volume":"67","author":"Caslini","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2014.10.005_bib184","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib185","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/jm3015298","article-title":"Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction","volume":"56","author":"Zhou","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib186","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2014.10.005_bib187","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/leu.2012.327","article-title":"Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l","volume":"27","author":"Chen","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.10.005_bib188","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib189","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ncomms2304","article-title":"Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors","volume":"3","author":"Yu","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.cancergen.2014.10.005_bib190","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/jm300917h","article-title":"Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L","volume":"55","author":"Anglin","year":"2012","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cancergen.2014.10.005_bib191","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1021\/ja206312b","article-title":"Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies","volume":"133","author":"Yao","year":"2011","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.cancergen.2014.10.005_bib192","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1039\/c3md00021d","article-title":"Synthesis, activity and metabolic stability of non-ribose containing inhibitors of histone methyltransferase DOT1L","volume":"4","author":"Deng","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.cancergen.2014.10.005_bib193","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0006-291X(86)90048-3","article-title":"3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60","volume":"135","author":"Glazer","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cancergen.2014.10.005_bib194","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergen.2014.10.005_bib195","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1182\/blood-2010-07-294827","article-title":"The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML","volume":"118","author":"Zhou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib196","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","article-title":"Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells","volume":"114","author":"Fiskus","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.10.005_bib197","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/cas.12386","article-title":"Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16","volume":"105","author":"Ueda","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cancergen.2014.10.005_bib198","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A\u00a0selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cancergen.2014.10.005_bib199","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.10.005_bib200","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml3003346","article-title":"Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2","volume":"3","author":"Verma","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.cancergen.2014.10.005_bib201","doi-asserted-by":"crossref","first-page":"21360","DOI":"10.1073\/pnas.1210371110","article-title":"Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation","volume":"109","author":"Qi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib202","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2014.10.005_bib203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776214002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776214002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:33Z","timestamp":1761896493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776214002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":203,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2210776214002312"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2014.10.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}